NCT03452306 - Bioequivalence Study of Metformin 750 mg Tablets XR Versus Glucophage® Long 750 mg Tablets XR In Normal Healthy Subjects Under Fasting and Fed Conditions | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 15, 2017

Primary Completion Date

July 22, 2017

Study Completion Date

July 22, 2017

Conditions

Bioequivalence

Interventions

DRUG

Metformine

"First aIntervention Period:~Single administered dose of Metformin (750 mg tablet extended-release) in a fasting condition"

DRUG

Glucophage® Long

"Second Intervention Period:~Single administered dose of Glucophage® (750 mg tablet extended-release) in a fasting condition"

DRUG

Metformin

"Third Intervention Period:~Single administered dose of Metformin (750 mg tablet extended-release) in a fed condition"

DRUG

Glucophage® Long

"Fourth Intervention Period:~Single administered dose of Metformin (750 mg tablet extended-release) in a fed condition"

Trial Locations (1)

Yarosslavl Clinical Hospital #3, Yaroslavl